GERMANTOWN, Md., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Orgenesis, a global biotech company working to unlock the full potential of cell and gene therapies (CGTs), continues to grow the infrastructure of the advanced therapeutic POCare services and facilities supply business, Octomera. The appointment of Gerhard Bauer as the Vice President of Global Product Implementation at Octomera has been made to enhance the existing process development, regulatory, engineering, equipment, and data/technical service offering and POCare Center hubs. He is also an active contributor to the evolution of the flexible facilities format, Octomera Mobile Process Labs & Units (OMPULs) and network, which allow the traditional facility build time to be cut down from years to under 6 months.
"Gerhard is an industry pioneer with unmatched expertise. We worked together in his prior role as Director of the UC Davis GMP Laboratory, and I have been continually impressed with his industry knowledge, technical prowess, and leadership skills," commented Vered Caplan, CEO of Orgenesis and Octomera. "We are thrilled to continue the relationship and see his level of expertise as critical to carrying forward our mission of decentralizing access to advanced medicines. Our platform is built to enable rapid advanced therapy innovation via smart engineering to lower costs, and streamline cell and gene therapy production, to benefit patients worldwide–something Gerhard is truly passionate about."
Mr. Bauer has been an innovator in the pharmaceutical industry since the 1990s, when he was inspired by personal experiences to pursue a different type of medicine. He began his time at Johns Hopkins University where he was part of the team that developed the first stem cell gene therapy for HIV. Later in the 90s, he went on to pioneer and commercialize a stem cell gene therapy for HIV and ADA SCID (bubble boy disease) at the University of Southern California's Children's Hospital Los Angeles.
In 2002, Bauer moved to set up a new GMP laboratory at Washington University in St. Louis that quickly became acclaimed for its work. In 2006, he was ...